Get alerts on this situation

We’ll email you as it develops, and you can follow the whole thread from day one.

Unsubscribe anytime.

[SITUATION] · [ACTIVE]

6 clusters · 27 sources · 47 days · First seen about 2 months ago · Last updated about 22 hours ago

Categories: HEALTH

Argentina ANMAT regulatory actions

Entities: Ministry of Health · Retailers and kiosk owners · Colegio de Farmacéuticos de la Provincia de Buenos Aires (COLFARMA) · Argentina · Eduardo Midence

Overview

Since June 2026 ANMAT has intensified enforcement across cosmetics, cleaning agents, medical devices and pharmacy sales, barring several products for lacking proper sanitary registration and recalling contaminated cleaning‑product batches. It also tightened qualifications for technical directors of medical‑device firms, revoked 15 non‑compliant certifications, and advanced legislation on pharmacy sales, including digital provisions.

On 27 July 2026 ANMAT issued Disposition 4714/2026, formally authorising over‑the‑counter sales of ten active‑ingredient groups that have demonstrated safety, efficacy, a wide therapeutic margin and at least five years of prescription‑only marketing without serious adverse events. New batches must bear a QR code linking to a digital prospectus, while existing stock may remain on shelves. The authorised ingredients include trimebutine maleate, levocetirizine, fexofenadine, dimenhydrinate, a nafazolina + feniramina combination, olopatadine, carbocisteine, aluminum‑chloride hexahydrate, a calcium‑carbonate‑arnica‑silver‑nitrate blend and topical ivermectin 0.5 % lotion.

Professional bodies such as COLFARMA and pharmacists in Santa Cruz warned that broader self‑medication could pose health risks, whereas merchants in San Juan welcomed the commercial opportunity. The parallel crackdown on unsafe products and expansion of vetted OTC medicines illustrates ANMAT’s dual strategy of consumer protection and market liberalisation.

Claims

What the coverage asserts, and how well corroborated each claim is across sources.

[● 12 SOURCES] ANMAT authorized over‑the‑counter sale of ten drug groups through Disposition 4714/2026.
[● 11 SOURCES] The authorised active ingredients are trimebutine maleate, levocetirizine, fexofenadine, dimenhydrinate, nafazolina + feniramina, olopatadine, carbocisteine, aluminum chloride hexahydrate, calcium‑car (ANMAT)
[● 10 SOURCES] The regulation applies only to the specific concentrations, pharmaceutical forms and routes of administration defined in the disposition. (supported)
[● 10 SOURCES] To qualify, a drug must have shown safety, efficacy, a wide therapeutic margin and at least five years of prescription‑only marketing without serious adverse events. (ANMAT)
[● 10 SOURCES] The measure follows the Ministry of Health's Resolution 284/2024, which tasked ANMAT with reviewing OTC eligibility. (Ministry of Health (Argentina))
[● 5 SOURCES] Existing stock can continue to be sold with current labeling; new batches must carry a QR code and updated labeling linking to a digital prospectus. (ANMAT)
[● 2 SOURCES] Pharmacy professional groups, including COLFARMA, warned that the OTC expansion poses safety risks for patients. (COLFARMA)
[○ 1 SOURCE] Merchants in San Juan supported the policy, saying over‑the‑counter sales in kiosks would boost profitability and convenience for customers. (San Juan merchants)

Timeline

about 22 hours ago

[HEALTH] 13 sources
Argentina's ANMAT authorizes over‑the‑counter sale of ten drug groups
ANMAT’s Disposition 4714/2026 makes ten drug groups OTC in Argentina, meeting safety criteria; pharmacists warn of risks, while merchants praise the consumer convenience.
2 days ago

[HEALTH] 4 sources
Argentina's ANMAT bans Clean Laby and Clorquim cleaning products
Argentina's ANMAT ordered removal of Clean Laby and Clorquim cleaning products for missing registration, while also tightening rules for medical‑device firms and proposing changes to pharmacy sales.
9 days ago

[HEALTH] 4 sources
Argentina's ANMAT bans several sunscreens and cleaning products in Buenos Aires
ANMAT banned three unregistered sunscreens and three cleaning products in Buenos Aires, citing missing documentation and illegal import, and also withdrew a Dysport lot.
15 days ago

[HEALTH] 2 sources
Argentina's ANMAT bans dozens of cosmetics over health‑risk concerns
ANMAT bans multiple cosmetics from six brands in Argentina, citing missing health registration and potential formaldehyde content, and orders their removal from stores and online sales.
22 days ago

[HEALTH] 2 sources
Argentina's ANMAT bans medical products from Lead Cables after unapproved factory found
ANMAT has banned Lead Cables' medical products nationwide after finding the firm operating in an unlicensed facility and suspended its manufacturing certificate.
about 2 months ago

[HEALTH] 3 sources
Argentina's ANMAT bans illegal child cosmetics and a falsified morphine medication
ANMAT barred several unregistered child cosmetics from China and recalled a falsified morphine drug found in Santa Fe, citing health risks and illegal importation.

Sources

0223.com.ar · canal13sanjuan.com · chacodiapordia.com · diariodelujan.com · diarioelzondasj.com.ar · diariondi.com · economiasustentable.com · elfueguino.com.ar · hindi.newslaundry.com · i-portal.pl · lagacetadeloeste.com.ar · lajornadaweb.com.ar · localmarketingstars.com · mediosrioja.com.ar · naoviu.com.br · nogoyatimes.com · noticias.perfil.com · notinor.com · perfil.com · pharmabiz.net · radiobicentenario.com.ar · radioeme.com · sanluis24.com.ar · santotomealdia.com.ar · sitiosargentina.com.ar · tiemposur.com.ar · topicosbrasil.com

This summary has been updated 4 times: see revision history